World's Best Scientists 2026 revealed!

Overview

Shosaku Nomura is affiliated with Kansai Medical University in Japan and has a research focus primarily in the field of medicine, with a significant emphasis on oncology. Their work spans multiple subfields, including oncology, pulmonary and respiratory medicine, cancer research, surgery, and molecular biology.

Nomura's research topics include colorectal cancer treatments and studies, lung cancer treatments and mutations, gastric cancer management and outcomes, cancer genomics and diagnostics, lung cancer diagnosis and treatment, cancer immunotherapy and biomarkers, and lung cancer research studies.

Frequent coauthors collaborating with Nomura are Takayuki Yoshino, Akihiro Sato, Masashi Wakabayashi, Tomohiro Nishina, and Hiroya Taniguchi.

The recurring publication venues where Nomura's work appears include the Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, Cancer Medicine, and ESMO Open.

Notable publications by Nomura include:

  • Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603), 2020, Journal of Clinical Oncology
  • Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial, 2021, Nature Medicine
  • Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial, 2023, The Lancet
  • Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial), 2020, Clinical Cancer Research

Best Publications

  • Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts

    T Komori;H Yagi;S Nomura;A Yamaguchi

  • High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles

    Yasuhiko Miyazaki;Shosaku Nomura;Tetsuya Miyake;Hideo Kagawa

  • Measuring circulating cell-derived microparticles

    W. Jy;L. L. Horstman;J. J. Jimenez;Y. S. Ahn

  • Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus.

    Shosaku Nomura;Masahiko Suzuki;Kaoruko Katsura;Gui Lan Xie

  • Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

    Kiyotaka Yoh;Takashi Seto;Miyako Satouchi;Makoto Nishio

  • Expression of oxytocin receptor in human pregnant myometrium.

    T Kimura;M Takemura;S Nomura;T Nobunaga

  • Function and role of microparticles in various clinical settings.

    Shosaku Nomura;Yukio Ozaki;Yasuo Ikeda

  • Significance of chemokines and activated platelets in patients with diabetes.

    S. Nomura;A. Shouzu;S. Omoto;M. Nishikawa

  • In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections.

    T Ikeda;S Nomura;A Yamaguchi;T Suda

  • NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.

    N Oyaizu;R Yasumizu;M Miyama-Inaba;S Nomura

  • Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura

    Shosaku Nomura;Kazuo Dan;Tomomitsu Hotta;Kingo Fujimura

  • The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

    Shosaku Nomura;Norihito Inami;Akira Shouzu;Seitarou Omoto

  • TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

    Yasutoshi Kuboki;Tomohiro Nishina;Eiji Shinozaki;Kentaro Yamazaki

  • Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.

    Masataka Kuwana;Shosaku Nomura;Kingo Fujimura;Toshiro Nagasawa

  • Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.

    Kingo Fujimura;Masataka Kuwana;Yoshiyuki Kurata;Masahiro Imamura

  • Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.

    Noriko Inagaki;Kayoko Kibata;Takeshi Tamaki;Toshiki Shimizu

  • Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial.

    Yoshiaki Nakamura;Wataru Okamoto;Takeshi Kato;Taito Esaki

  • Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.

    Tomoyuki Hishida;Shogo Nomura;Motoki Yano;Hisao Asamura

  • Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab

    Aya Nakaya;Takayasu Kurata;Hiroshige Yoshioka;Yuki Takeyasu

  • Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes.

    Shosaku Nomura;Akira Shouzu;Seitaro Omoto;Takashi Hayakawa

Frequent Co-Authors

Yuzuru Kanakura
Yuzuru Kanakura Osaka University
Yasuo Ikeda
Yasuo Ikeda Waseda University
Akifumi Takaori-Kondo
Akifumi Takaori-Kondo Kyoto University
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Yukio Ozaki
Yukio Ozaki University of Yamanashi
Shigeru Chiba
Shigeru Chiba University of Tsukuba
Yutaka Yatomi
Yutaka Yatomi University of Tokyo
Tsuneyasu Kaisho
Tsuneyasu Kaisho Wakayama Medical University
Susumu Ikehara
Susumu Ikehara Kansai Medical University
Masafumi Taniwaki
Masafumi Taniwaki Kyoto Prefectural University of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways and flexible online degrees can be a great option for those interested in healthcare careers beyond traditional medical school. Many students now choose online or accelerated programs to save time and balance their studies with work or family commitments.

Nurses looking to advance may consider online dnp programs without dissertation—ideal for those seeking leadership roles or advanced practice without the research component of traditional DNP degrees. Alternatively, those hoping to enter the workforce quickly can check out an lpn accelerated program to fast-track their journey to becoming a licensed practical nurse.

For nurses interested in specialized care, the shortest pmhnp program is an efficient way to become a Psychiatric Mental Health Nurse Practitioner and meet the growing mental health needs in the U.S.

If you are considering the business side of healthcare, pursuing a health care administration degree online opens doors to management and leadership positions in hospitals and clinics. These options offer flexible, accessible, and cost-effective ways to advance your healthcare career.

Best Scientists Citing Shosaku Nomura

Trending Scientists

Recently Published Articles